ASXC
Price
$0.25
Change
-$0.00 (-0.00%)
Updated
Apr 19, 6:59 PM EST
20 days until earnings call
DMTK
Price
$0.64
Change
+$0.05 (+8.47%)
Updated
Apr 19, 6:59 PM EST
12 days until earnings call
Ad is loading...

Compare predictions ASXC vs DMTK

Header iconASXC vs DMTK Comparison
Open Charts ASXC vs DMTKBanner chart's image
Asensus Surgical
Price$0.25
Change-$0.00 (-0.00%)
Volume$614.31K
CapitalizationN/A
DermTech
Price$0.64
Change+$0.05 (+8.47%)
Volume$494.11K
CapitalizationN/A
View a ticker or compare two or three
ASXC vs DMTK Comparison Chart

Loading...

ASXCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DMTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ASXC vs. DMTK commentary
Apr 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASXC is a StrongBuy and DMTK is a Hold.

COMPARISON
Comparison
Apr 20, 2024
Stock price -- (ASXC: $0.25 vs. DMTK: $0.59)
Brand notoriety: ASXC and DMTK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ASXC: 53% vs. DMTK: 80%
Market capitalization -- ASXC: $59.84M vs. DMTK: $23.91M
ASXC [@Medical Specialties] is valued at $59.84M. DMTK’s [@Medical Specialties] market capitalization is $23.91M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASXC’s FA Score shows that 0 FA rating(s) are green whileDMTK’s FA Score has 0 green FA rating(s).

  • ASXC’s FA Score: 0 green, 5 red.
  • DMTK’s FA Score: 0 green, 5 red.
According to our system of comparison, ASXC is a better buy in the long-term than DMTK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASXC’s TA Score shows that 5 TA indicator(s) are bullish while DMTK’s TA Score has 5 bullish TA indicator(s).

  • ASXC’s TA Score: 5 bullish, 5 bearish.
  • DMTK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, DMTK is a better buy in the short-term than ASXC.

Price Growth

ASXC (@Medical Specialties) experienced а -9.13% price change this week, while DMTK (@Medical Specialties) price change was -10.99% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.24%. For the same industry, the average monthly price growth was -4.56%, and the average quarterly price growth was +9.29%.

Reported Earning Dates

ASXC is expected to report earnings on Aug 07, 2024.

DMTK is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Medical Specialties (-2.24% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ASXC with price predictions.
OPEN
A.I.dvisor published
a Summary for DMTK with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
ASXC($59.8M) has a higher market cap than DMTK($23.9M). ASXC YTD gains are higher at: -20.759 vs. DMTK (-66.229). ASXC has higher annual earnings (EBITDA): -74.39M vs. DMTK (-97.89M). DMTK has more cash in the bank: 55.9M vs. ASXC (21.1M). ASXC has less debt than DMTK: ASXC (5.68M) vs DMTK (54.4M). DMTK has higher revenues than ASXC: DMTK (15.3M) vs ASXC (8.58M).
ASXCDMTKASXC / DMTK
Capitalization59.8M23.9M250%
EBITDA-74.39M-97.89M76%
Gain YTD-20.759-66.22931%
P/E RatioN/AN/A-
Revenue8.58M15.3M56%
Total Cash21.1M55.9M38%
Total Debt5.68M54.4M10%
FUNDAMENTALS RATINGS
ASXC vs DMTK: Fundamental Ratings
ASXC
DMTK
OUTLOOK RATING
1..100
7554
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
6493
P/E GROWTH RATING
1..100
10039
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ASXC's Valuation (39) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for DMTK (96) in the null industry. This means that ASXC’s stock grew somewhat faster than DMTK’s over the last 12 months.

ASXC's Profit vs Risk Rating (100) in the Miscellaneous Commercial Services industry is in the same range as DMTK (100) in the null industry. This means that ASXC’s stock grew similarly to DMTK’s over the last 12 months.

DMTK's SMR Rating (98) in the null industry is in the same range as ASXC (99) in the Miscellaneous Commercial Services industry. This means that DMTK’s stock grew similarly to ASXC’s over the last 12 months.

ASXC's Price Growth Rating (64) in the Miscellaneous Commercial Services industry is in the same range as DMTK (93) in the null industry. This means that ASXC’s stock grew similarly to DMTK’s over the last 12 months.

DMTK's P/E Growth Rating (39) in the null industry is somewhat better than the same rating for ASXC (100) in the Miscellaneous Commercial Services industry. This means that DMTK’s stock grew somewhat faster than ASXC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASXCDMTK
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 23 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ASXCDaily Signal changed days agoGain/Loss if shorted
 
Show more...
DMTKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AKTS0.510.01
+1.23%
Akoustis Technologies
TKR84.190.36
+0.43%
Timken Company (The)
BKNG3430.14-13.77
-0.40%
Booking Holdings
BOOM16.56-0.12
-0.72%
DMC Global
INFN4.66-0.12
-2.51%
Infinera Corp

ASXC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASXC has been loosely correlated with RVTY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ASXC jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASXC
1D Price
Change %
ASXC100%
-2.81%
RVTY - ASXC
36%
Loosely correlated
-1.09%
ITGR - ASXC
29%
Poorly correlated
-0.58%
ALGN - ASXC
29%
Poorly correlated
+0.40%
CSTL - ASXC
28%
Poorly correlated
+1.91%
NAOV - ASXC
28%
Poorly correlated
N/A
More

DMTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMTK has been loosely correlated with SRTS. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if DMTK jumps, then SRTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMTK
1D Price
Change %
DMTK100%
-0.17%
SRTS - DMTK
34%
Loosely correlated
N/A
BIO - DMTK
32%
Poorly correlated
-3.38%
QTI - DMTK
30%
Poorly correlated
-0.04%
MYGN - DMTK
29%
Poorly correlated
-0.70%
TWST - DMTK
29%
Poorly correlated
-0.74%
More